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Abstract
There is an ever-growing trend towards less-invasive procedures in all fields ofmedicine.We designed an animal study to prove the concept that
trans-apical aortic valve replacement from an incision within the umbilicus through a single channel for instruments is feasible, which would be a
major leap towards no-scar cardiac surgery. In three adult pigs, after creating a single 3-cm incision at a place where the human umbilicus would
be, we introduced a 30F sheath through a tunnel created by an endoscopic vein-harvesting device up to the cardiac apex, through it and up to the
left ventricle simulating the approach for trans-apical aortic valve replacement. We used a standard Amplatz nitinol occluder to seal the defect in
ventricle wall later. The animals were followed up for 1 h. Blood loss was minimal, and no tamponade occurred in any of the animals. In addition,
we performed a test with water column static pressure to evaluate the impact of preclotting on the sealing properties of the occluders: 1 min
flow-through was 2860  176 ml for the standard occluders and 348  56 ml for preclotted occluders ( p < 0.001).
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Keywords: Minimally invasive cardiac surgery; No-scar surgery; Trans-catheter valve replacement; Occluder; Trans-apical access
www.elsevier.com/locate/ejcts
European Journal of Cardio-thoracic Surgery 36 (2009) 773—7751. Introduction
Off-pump trans-left-ventricular approach for aortic valve
replacement currently is being performed through a small
mini-thoracotomy and has been proven to be safe and
effective [1,2]. The limiting factor for this procedure to
become even less invasive is the closure of left ventricular
defect after catheter withdrawal. It has been reported
previously that repair of the left ventricle with a standard
sutureless closing device in a thoracoscopic fashion is feasible
[3]. The goal of this study is to prove that distant single-
orifice, single-channel access is sufficient to perform a trans-
apical valve replacement procedure, which would be a major
leap towards no-scar cardiac surgery.
As the use of a standard occluder was shown previously to
be associated with increased blood loss during the procedure
[3], as a side task we decided to test preclotting of the
occluder with non-heparinised blood to minimise blood loss
during the procedure.* Corresponding author. Current address: Center of Cardiac Surgery, Pauls
Stradins Clinical University Hospital, Pilsonu str. 13, Riga, LV-1002, Latvia.
Tel.: +371 6 7069221; fax: +371 6 7069421.
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An acute animal study was performed in three adult pigs,
51  2.0 kg weight, under general anaesthesia, equipped
with arterial and venous pressure lines and electrocardio-
graph (ECG) monitoring. In five adult humanmale volunteers,
we measured the mean distance between sternum and
umbilicus to be 15.6  1.8 cm, which was used in the animals
as a reference. At this distance, a single incision of
approximately 3 cm was performed (Fig. 1), a tunnel towards
the sternum just above the abdominal fascia was created in a
blunt fashion. A retractor for endoscopic vein harvesting
(Karl Storz, Tuttlingen, Germany) equipped with a camera
was introduced into the tunnel. Subsequently, using endo-
scopic scissors, an incision in the fascia was created just
below the xyphoid process to reach the pericardium. A
window of at least 3  4 cm was created in the pericardium
and the apex of the heart was visualised (Video 1). From this
point, the procedure of gaining trans-apical access and
closing it using a 12-mm Amplatzer occluder for interven-
tricular septal defect closure (Aga, Golden Valley, MN, USA) is
described in detail in Tozzi et al. [3]. In brief, it was as
follows: after heparin injection (100 IU kg1), under fluoro-
scopic control, we punctured the heart, positioned a guide
wire and inserted a 30F sheath through the tunnel and the
cardiac apex, into the left ventricle, simulating the approach
for aortic valve replacement. Subsequently, the sheath wasSurgery. Published by Elsevier B.V. All rights reserved.
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Fig. 2. (A) Fluoroscopic view of the occluder after deployment. (B) Gross
anatomical view of heart after necropsy with the occluder correctly posi-
tioned.
Fig. 1. An incision 3 cm long 16 cm below the sternum.removed and the ventricle access closed with an occluder
(Fig. 2A and Video 1, see Video 2 for a fluoroscopic view).
Animals were then followed up for 1 h, and haemodynamics
data were collected. The animals were subsequently
sacrificed and gross anatomy examination of the heart
carried out (Fig. 2B). Pericardial bleeding was assessed using
a conventional suction device during the procedure.
All the pigs received care in compliance with ‘the Guide
for the Care and Use of Laboratory Animals’ by the Institute
of Laboratory Animal Resources (NIH publication 85—23,
revised 1985). The protocol was approved by the Institutional
Committee on Animal Research.
To test the effectiveness of preclotting the occluder in
minimising blood loss, we conducted a separate in vitro test
using three standard and three occluders preclotted with
unheparinised blood for 15 min with a water column static
pressure equal to 100 mmHg, measuring the flow of water
through the occluders in 1 min.
We used Student’s t-test for comparing means and chose a
P-value below 0.05 as the threshold for statistical signifi-
cance. Values are reported as mean  standard deviation
(SD).
3. Results
Six occluders were successfully deployed in three animals
(two occluders per animal; second after 1-h interval) in
<1 min per device. Endoscopic view was acceptable and
allowed for visualisation of coronary vasculature (Video 1).
No major arrhythmias were detected during or after device
deployment. Baseline mean blood pressure was
61  15 mmHg, it decreased to 52  10 mmHg during deploy-
ment and remained stable at 64  12 mmHg after the
procedure. Precise measurements of blood loss with standard
occluders were performed by Tozzi et al. previously and were
found to be 800  20 ml in 3 h (100  5 ml in 3 h when using a
pericardial cuff) [3] and were not repeated, blood loss with
preclotted occluders was 100  30 ml in 1 h (80 ml during
deployment).In the in vitro test, 1-min flow-through was 2860  176 ml
for the standard occluders and 348  56 ml for preclotted
occluders ( p < 0.001) with a flow reduction by a ratio of 8.2
— similarly to the decrease in blood loss by a ratio of 9.4 when
using a pericardial cuff, as reported by Tozzi et al. [3].
4. Conclusions
Although the results are very preliminary, we have
demonstrated that a defect in the free wall of the left
ventricle can be safely closed in an endoscopic fashion during
a single-port procedure, leaving a nearly invisible scar in the
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possible new surgical access for trans-apical aortic valve
replacement offering better cosmesis, less pain and faster
recovery, with all the benefits of the trans-apical route.
Our in vitro tests and in vivo experience have shown that
preclotting of the occluder with non-heparinised blood
significantly improves its sealing capabilities by reducing
liquid flow through the device.
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Natural orifice translumenal endoscopic surgery (NOTES)
is an intensely discussed and an emerging technique in
visceral surgery today. Embracing the NOTES philosophy and
principles, Dr Kalejs and his colleagues took an innovative
approach to both access to the heart and closure of the
perforated ventricle [1]. They introduced the concept of
single-port surgery in trans-apical trans-catheter valve
implantation, by combining endoscopic and endovascular
techniques. The endoscopic part consisted of a subcutaneous
tunnel from the umbilicus to the pericardium and its
fenestration. The cardiac apex was dilated creating a 1-cm
defect and was successfully closed by endovascular means
using a guide wire, sheath and a preclotted Amplatzer septal
defect occluder. The results in six animals of a porcine model
showed successful haemostatic sealing, with an operation
wound that would be normally obviscated in the human
umbilicus ‘button’.
As mentioned by the authors, single-port surgery or NOTES
for valve replacement is not unrealistic, and may be a vision
compatible with the future. Although trans-apical trans-
catheter valve implantation requires only a small thoracot-
omy, the recommended trans-umbilical access is intriguing,
as it is even less invasive with the potential of lowering
morbidity. This technique could bring particular benefits in
high-risk patients such as octogenarians with previous bypass
surgery requiring valve replacement. In NOTES, considerable
challenges remain, such as the safety of the access
technique, the adequate closure of the perforated organ
and sterility issues. The development of highly flexible
instruments including triangulation of the visual field is
crucial. Another objective is the achievement of adequatepatients with aortic stenosis: a position statement from the European
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version, at doi:10.1016/j.ejcts.2009.06.040.mment
rans-umbilical incision
retraction of the organs while working through a single
channel. Despite these difficulties and the fact that NOTES is
technically extremely demanding with a steep learning
curve, it obviously gains more and more momentum.
However, ‘until we are forced to accept disruptive technol-
ogies . . . either driven by patient demand, . . . superiority of
the therapy, and/or favourable reimbursement, most of us
will not leave the comfort of our current practices . . . for
something new [2].’ NOTES may have advantages and should
be therefore considered as a promising new technique.
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